Association of p16INK4a overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue
- 28 December 2010
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 33 (11) , 1622-1627
Abstract
Background: The aim of this study was to examine biomolecular profiles in a cohort of young adults with squamous cell cancers (SCCs) of the oral tongue.Methods: We identified all patients aged 18 to 39 years diagnosed with SCC of the oral tongue at our institution. Immunohistochemical (IHC) staining was performed for p16INK4a, epidermal growth factor receptor (EGFR), phosphorylated‐EGFR (pEGFR), p53, and ERCC1. Human papillomavirus (HPV) testing was performed using in situ hybridization (ISH) and polymerase chain reaction (PCR). Biomarker expression and HPV status were correlated with outcomes.Results: We identified 25 patients with sufficient tumor samples. Median age at diagnosis was 30 years (range, 20–39 years). p16INK4a overexpression was observed in 11 of 25 patients, whereas HPV‐16 positivity was observed in none of the tumor samples by ISH and 2 of the tumor samples by PCR. p16INK4a positivity was correlated with improved relapse‐free survival (hazard ratio [HR] = 0.23, p = .01) and overall survival (HR = 0.28, p = .05). Neither EGFR, pEGFR, p53, nor excision repair cross‐complementing rodent repair deficiency, complementation group 1 (ERCC1) expression correlated with outcome on univariate analysis.Conclusions: p16INK4a overexpression was common and was a marker of favorable prognosis. p16INK4a overexpression was not a reliable predictor of HPV positivity in our cohort. © 2010 Wiley Periodicals, Inc. Head Neck, 2011Keywords
This publication has 25 references indexed in Scilit:
- Concurrent Human Papillomavirus–Associated Tonsillar Carcinoma in 2 CouplesThe Journal of Infectious Diseases, 2009
- Never‐smokers, never‐drinkers: Unique clinical subgroup of young patients with head and neck squamous cell cancersHead & Neck, 2009
- Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysisHead & Neck, 2009
- Recent changes in the epidemiology of head and neck cancerCurrent Opinion in Oncology, 2009
- EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal CancerJournal of Clinical Oncology, 2008
- Individualized Treatment Selection in Patients With Head and Neck Cancer: Do Molecular Markers Meet the Challenge?Journal of Clinical Oncology, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Clinical Implications of Human Papillomavirus in Head and Neck CancersJournal of Clinical Oncology, 2006
- Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable PrognosisJournal of Clinical Oncology, 2006